Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02361268 · ClinicalTrials.gov registry record · NA

End-Stage Renal Disease Intra-dialysis Lifestyle Education Study

A NA study of End Stage Renal Disease, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT02361268: Completed NA study of End Stage Renal Disease, sponsored by Vanderbilt University Medical Center.

NCT02361268 is a NA study of End Stage Renal Disease that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 67 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02361268, a NA study of End Stage Renal Disease, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effects of intra-dialysis yoga to an educational program among patients with end-stage renal disease. The investigators hypothesize that yoga as compared to the educational program will significantly improve quality of life.

Primary Outcome

The Kidney Disease Quality of Life-36 instrument is a 36-item instrument that contains a generic core (Short Form-12) plus the burden of kidney disease, symptoms/problem of kidney disease, and effects of kidney disease scales.

Conditions Studied

Interventions

  • BEHAVIORAL Educational program
  • BEHAVIORAL Intradialysis-yoga

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2015-07
Est. Completion 2017-05
Phase NA

What the finished NCT02361268 record still lists

NCT02361268 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (92% lower).

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which Educational program is the first listed.

NCT02361268 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT02361268 about?

NCT02361268 is a clinical study titled "End-Stage Renal Disease Intra-dialysis Lifestyle Education Study". The purpose of this study is to compare the effects of intra-dialysis yoga to an educational program among patients with end-stage renal disease. The investigators hypothesize that yoga as compared to the educational program will significantly improve quality of life.

What is the current status of trial NCT02361268?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2015-07. Estimated completion is 2017-05.

What conditions does trial NCT02361268 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT02361268?

The interventions under investigation include: Educational program (BEHAVIORAL), Intradialysis-yoga (BEHAVIORAL).

Who is sponsoring clinical trial NCT02361268?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02361268 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02361268's enrollment target sits among peer trials

67 45th of 86 higher than 42 of 86 other End Stage Renal Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03213002 · 67 participants · Phase 1

    Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • NCT04115163 · 67 participants · Phase 2

    Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

  • NCT04315324 · 67 participants · Phase 1

    Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

  • NCT04532424 · 67 participants · NA

    Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02361268, the US trial registry maintained by the National Library of Medicine. NCT02361268 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.